Back to Awarded Treatment Trials
Awarded Trial: 10T-1432
Grant ID
10T-1432
Illness
Schizophrenia
Primary Drug/Intervention
BH4
Primary Dosage
N/A
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Cancelled
Investigator
Lieberman
Sample Size
72
Duration of Study Period for Each Subject
70 days
Outcome Measurements
N/A
Results
Cancelled due to low patient enrollment.
Publication
N/A
Link
N/A
PI Name
Jeffrey Lieberman
Degree
MD
Center
Columbia University Medical Center
Institution
Columbia University
Address
1051 Riverside Drive, Unit 4
City or Town
New York
State or Province
New York
Zip or Postal Code
10032
Country
USA
Email Address
jlieberman@columbia.edu